AQST

NASD Aquestive Therapeutics, Inc.
Oct 29, 2026 · 1:21 PM ET DELAYED Market Open

$4.11 ↓ -0.13 (-2.96%) Trading Down from the previous close of $4.23, $0.19 below the day’s high of $4.29

YTD change
-36.46%
vs 20-day SMA
-5.22%
vs 200-day SMA
-2.34%

Price ranges

Previous day
$4.01 $4.23
open $4.05 close $4.23
+$0.18 (+4.44%)
Today
$4.09 $4.29
open $4.17 now $4.11
-$0.06 (-1.56%)
Past week
$3.92 $4.23
from $4.08 now $4.11
+$0.03 (+0.61%)
Past month
$3.65 $4.98
from $4.63 now $4.11
-$0.52 (-11.34%)
This year
$2.93 $6.59
from $6.46 now $4.11
-$2.36 (-36.46%)

Price & Performance

+0.18 (+4.44%) / 6M

$3.46$4.15$4.84$5.53Apr 29Jul 30Oct 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 80.2% away from all-time highs of $20.70
  • AQST is down 36% since the beginning of the year
  • AQST is down 37% over the past 12 months
  • AQST is down 11% over the past 1 month
  • 23% of all AQST investors are betting against AQST

AQST reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -34.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.18
Earnings momentum -50.0% Quarterly EPS growth
Quarterly change -50.0%

Valuation

P/E ratio N/A
Enterprise value $579.3M
Beta 1.53

Balance sheet & scale

IncomeN/A
Revenue$54.1M
Cash$98.5M
Debt$149.1K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $535.9M

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,288.30 +0.50%
JNJ Johnson & Johnson $271.04 +0.86%
ABBV AbbVie, Inc. $285.99 -0.14%
MRK Merck & Co., Inc. $140.93 -0.63%
RHHVF Roche Holding Ltd $487.52 +1.44%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.